Healthy VolunteersLSDLSD

LSD enhances suggestibility in healthy volunteers

This within-subjects, placebo-controlled study (n=10) found that the influence of suggestion is enhanced by LSD, especially in individuals with high trait 'conscientiousness', which may have implications for the use of LSD in psychotherapy.

Authors

  • Bolstridge, M.
  • Carhart-Harris, R. L.
  • Feilding, A.

Published

Psychopharmacology
individual Study

Abstract

Rationale: Lysergic acid diethylamide (LSD) has a history of use as a psychotherapeutic aid in the treatment of mood disorders and addiction, and it was also explored as an enhancer of mind control.Objectives: The present study sought to test the effect of LSD on suggestibility in a modern research study.Methods: Ten healthy volunteers were administered with intravenous (i.v.) LSD (40-80 μg) in a within-subject placebo-controlled design. Suggestibility and cued mental imagery were assessed using the Creative Imagination Scale (CIS) and a mental imagery test (MIT). CIS and MIT items were split into two versions (A and B), balanced for ‘efficacy’ (i.e. A≈B) and counterbalanced across conditions (i.e. 50 % completed version ‘A’ under LSD). The MIT and CIS were issued 110 and 140 min, respectively, post-infusion, corresponding with the peak drug effects.Results: Volunteers gave significantly higher ratings for the CIS (p = 0.018), but not the MIT (p = 0.11), after LSD than placebo. The magnitude of suggestibility enhancement under LSD was positively correlated with trait conscientiousness measured at baseline (p = 0.0005).Conclusions: These results imply that the influence of suggestion is enhanced by LSD. Enhanced suggestibility under LSD may have implications for its use as an adjunct to psychotherapy, where suggestibility plays a major role. That cued imagery was unaffected by LSD implies that suggestions must be of a sufficient duration and level of detail to be enhanced by the drug. The results also imply that individuals with high trait conscientiousness are especially sensitive to the suggestibility-enhancing effects of LSD.

Unlocked with Blossom Pro

Research Summary of 'LSD enhances suggestibility in healthy volunteers'

Study Details

Cited By (105)

Papers in Blossom that reference this study

Participant experiences of therapeutic touch in psilocybin-assisted therapy

Carter, A., Gardner, J., Ham, R. et al. · OSF Preprints (2025)

A Transformative Trip? Experiences of Psychedelic Use

Beit, C., Blevins, K., Evans, N. G. et al. · Neuroethics (2024)

Psychedelic-assisted psychotherapy: Where is the psychotherapy research?

Aday, J. S., Bradley, E. R., Fernandes-Osterhold, G. et al. · Psychopharmacology (2024)

Psychedelics and the 'inner healer': Myth or mechanism?

Barba, T., Carhart-Harris, R. L., Erritzoe, D. et al. · Journal of Psychopharmacology (2024)

11 cited
Treatment with psychedelics is psychotherapy: beyond reductionism

Brand, M., Gründer, G., Jungaberle, H. et al. · Lancet Psychiatry (2024)

Synthetic surprise as the foundation of the psychedelic experience

De Filippo, R., Schmitz, D. · Neuroscience and Biobehavioral Reviews (2024)

21 cited
Show all 105 papers
Ayahuasca ceremony leaders' perspectives on special considerations for eating disorders

Lafrance, A., Miller, A. K., Williams, M. · Eating Disorders - The Journal of Treatment & Prevention (2023)

The ego in psychedelic drug action - ego defenses, ego boundaries, and the therapeutic role of regression

Buchborn, T., Kartner, L., Kettner, H. et al. · Frontiers in Neuroscience (2023)

History repeating: guidelines to address common problems in psychedelic science

Fried, E. I., van Elk, M. · Therapeutic Advances in Psychopharmacology (2023)

Nature-themed video intervention may improve cardiovascular safety of psilocybin-assisted therapy for alcohol use disorder

Bentancourt, I., Bramen, J., Heinzerling, K. G. et al. · Frontiers in Psychiatry (2023)

Dark loops: contagion effects, consistency and chemosocial matrices in psychedelic-assisted therapy trials

Bedi, G., Muthukumaraswamy, S., Noorani, T. N. · Psychological Medicine (2023)

Harnessing placebo: Lessons from psychedelic science

Hartogsohn, I., Pronovost-Morgan, C., Ramaekers, J. G. · Journal of Psychopharmacology (2023)

Dosing and Therapeutic Conduct in Administration Sessions in Substance-Assisted Psychotherapy: A Systematized Review

Bright, S. J., Bruno, R., Sharbanee, J. M. et al. · Journal of Humanistic Psychology (2023)

Group format psychedelic-assisted therapy interventions: Observations and impressions from the HOPE trial

Beck, A., Byrne, K., Garland, E. L. et al. · Journal of Psychedelic Studies (2023)

14 cited
The association between naturalistic use of psychedelics and co-occurring substance use disorders

Gross, R., Lev-Ran, S., Rabinowitz, J. · Frontiers in Psychiatry (2023)

Canalization and plasticity in psychopathology

Carhart-Harris, R. L., Chandaria, S., Erritzoe, D. et al. · Neuropharmacology (2022)

Psychedelic Identity Shift: A Critical Approach to Set And Setting

Devenot, N., Garcia-Romeu, A., Johnson, M. W. et al. · Kennedy Institute of Ethics Journal (2022)

28 cited
Neural Mechanisms and Psychology of Psychedelic Ego Dissolution

Egan, G. F., Friston, K. J., Razi, A. et al. · Pharmacological Reviews (2022)

Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study

Cavanna, F., de la Fuente, L. A., Kuchar, M. et al. · Translational Psychiatry (2022)

90 cited
Pharmacological, Neural, and Psychological Mechanisms underlying Psychedelics: A Critical Review

van Elk, M., Yaden, D. B. · Neuroscience and Biobehavioral Reviews (2022)

21 cited
Pattern Breaking: A Complex Systems Approach to Psychedelic Medicine

Carhart-Harris, R. L., Hipólito, I., Mago, J. et al. · Psyarxiv (2022)

Psychedelic-Assisted Psychotherapy-A Systematic Review of Associated Psychological Interventions

Cavarra, M., Falzone, A., Kuypers, K. P. C. et al. · Frontiers in Psychology (2022)

Psychedelics and Psychotherapy: Cognitive-Behavioral Approaches as Default

Earp, D., Freidman-Wheeler, D., Graziosi, M. et al. · Frontiers in Psychology (2022)

Great Expectations: Recommendations for improving the methodological rigor of psychedelic clinical trials

Aday, J. S., Bradley, E. R., Heifets, B. D. et al. · Psychopharmacology (2022)

Remembering Molly: Immediate and delayed false memory formation after acute MDMA exposure

Blokland, A., Kloft, L., Ramaekers, J. G. et al. · European Neuropsychopharmacology (2022)

Predictors and potentiators of psychedelic-occasioned mystical experiences

Gandy, S. · Journal of Psychedelic Studies (2022)

Psychedelic Cognition-The Unreached Frontier of Psychedelic Science

Balaet, M. · Frontiers in Neuroscience (2022)

Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective

Clarke, G., Gillan, C. M., Harkin, A. et al. · Frontiers in Psychiatry (2021)

Right-Wing Psychedelia: Case Studies in Cultural Plasticity and Political Pluripotency

Devenot, N., Pace, B. A. · Frontiers in Psychology (2021)

Psychedelics, sociality, and human evolution

Rodríguez Arce, J. M., Winkelman, M. J. · Frontiers in Psychology (2021)

Do Psychedelics Change Beliefs?

Corlett, P. R., Hutchinson, B., Leptourgos, P. et al. · Psyarxiv (2021)

Cancer Healthcare Workers' Perceptions toward Psychedelic-Assisted Therapy: A Preliminary Investigation

Akroyd, A., Evans, W. J., Muthukumaraswamy, S. et al. · International Journal of Environmental Research and Public Health (2021)

22 cited
Moral Psychopharmacology Needs Moral Inquiry: The Case of Psychedelics

Dyck, E., Langlitz, N., Repantis, D. et al. · Frontiers in Psychiatry (2021)

28 cited
Exploring the Use of Psilocybin Therapy for Existential Distress: A Qualitative Study of Palliative Care Provider Perceptions

Acquaviva, K. D., LeBaron, V. T., Mayer, C. E. · Journal of Psychoactive Drugs (2021)

12 cited
LSD, madness and healing: Mystical experiences as possible link between psychosis model and therapy model

Falchi, M., Feilding, A., Palhano-Fontes, F. et al. · Psychological Medicine (2021)

Role of the 5-HT2A receptor in acute effects of LSD on empathy and circulating oxytocin

Avedisian, I., Eckert, A., Holze, F. et al. · Frontiers in Pharmacology (2021)

Psychedelics alter metaphysical beliefs

Carhart-Harris, R. L., Kettner, H., Letheby, C. et al. · Scientific Reports (2021)

Psychedelics and health behaviour change

Adams, C., Carhart-Harris, R. L., Douglass, H. et al. · Journal of Psychopharmacology (2021)

Improving cognitive functioning in major depressive disorder with psychedelics: a dimensional approach

Kuiperes, Z., Schreiber, R. · Neurobiology of Learning and Memory (2021)

Relational Processes in Ayahuasca Groups of Palestinians and Israelis

Carhart-Harris, R. L., Doblin, R., Ginsberg, N. et al. · Frontiers in Pharmacology (2021)

30 cited
Trial of Psilocybin versus Escitalopram for Depression

Baker-Jones, M., Blemings, A., Carhart-Harris, R. L. et al. · New England Journal of Medicine (2021)

927 cited
A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats

de Sousa Fernandes Perna, E. B., Fábregas, J. M., Kuypers, K. P. C. et al. · Psychopharmacology (2021)

Predicting Reactions to Psychedelic Drugs: A Systematic Review of States and Traits Related to Acute Drug Effects

Aday, J. S., Bloesch, E. K., Davis, A. K. et al. · ACS Pharmacology and Translational Science (2021)

Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing

Balaet, M., Buchborn, T., Carhart-Harris, R. L. et al. · Scientific Reports (2021)

112 cited
Psychedelics and Psychotherapy

Johnson, M. W., Nayak, S. · Pharmacopsychiatry (2020)

The History of Psychedelics in Psychiatry

Nichols, D. E., Walter, H. · Pharmacopsychiatry (2020)

Pivotal Mental States

Brouwer, A., Carhart-Harris, R. L. · Journal of Psychopharmacology (2020)

Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments

Feduccia, A. A., Garel, N., Greenway, K. T. et al. · Expert Review of Clinical Pharmacology (2020)

Isness: Using Multi-Person VR to Design Peak Mystical Type Experiences Comparable to Psychedelics

Chatziapostolou, M., de Haan, T., Freire, R. et al. · Association for Computing Machinery (2020)

32 cited
73 cited
Long-term effects of psychedelic drugs: A systematic review

Aday, J. S., Bloesch, E. K., Davis, A. K. et al. · Neuroscience and Biobehavioral Reviews (2020)

Modulation of Social Cognition via Hallucinogens and “Entactogens”.

Preller, K. H., Vollenweider, F. X. · Frontiers in Psychiatry (2019)

REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics

Carhart-Harris, R. L., Friston, K. J. · Pharmacological Reviews (2019)

Pharmacokinetics and subjective effects of a novel oral LSD formulation in healthy subjects

Borgwardt, S., Duthaler, U., Holze, F. et al. · British Journal of Clinical Pharmacology (2019)

States and traits related to the quality and consequences of psychedelic experiences

Carhart-Harris, R. L., Elliott, M. S., Maruyama, G. et al. · Psychology of Consciousness Theory Research and Practice (2019)

Long-lasting analgesic effect of the psychedelic drug changa: A case report

Ona, G., Troncoso, S. · Journal of Psychedelic Studies (2019)

A systematic study of microdosing psychedelics

Polito, V., Stevenson, R. J. · PLOS ONE (2019)

197 cited
How do psychedelics work?

Carhart-Harris, R. L. · Current Opinion in Psychiatry (2019)

Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions

Garcia-Romeu, A., Richards, W. A. · International Review of Psychiatry (2018)

DMT models the near-death experience

Carhart-Harris, R. L., Cassol, H., Erritzoe, D. et al. · Frontiers in Psychology (2018)

Unifying theories of psychedelic drug effects

Swanson, L. R. · Frontiers in Pharmacology (2018)

Neuroendocrine Associations Underlying the Persistent Therapeutic Effects of Classic Serotonergic Psychedelics

D’Souza, D. C., Schindler, E. A. D., Sloshower, J. A. et al. · Frontiers in Pharmacology (2018)

Dark Classics in Chemical Neuroscience: Lysergic Acid Diethylamide (LSD)

Nichols, D. E. · ACS Chemical Neuroscience (2018)

Is LSD toxic?

Grob, C. S., Nichols, D. E. · Forensic Science International (2018)

The hidden therapist: evidence for a central role of music in psychedelic therapy

Carhart-Harris, R. L., Evans, J., Feilding, A. et al. · Psychopharmacology (2018)

213 cited
Psychedelics and the essential importance of context

Carhart-Harris, R. L., Erritzoe, D., Haijen, E. C. H. M. et al. · Journal of Psychopharmacology (2018)

Connectome-harmonic decomposition of human brain activity reveals dynamical repertoire re-organization under LSD

Atasoy, S., Carhart-Harris, R. L., Deco, G. et al. · Scientific Reports (2017)

Clinical Applications of Hallucinogens: A Review

Addy, P. H., Garcia-Romeu, A., Kersgaard, B. · Experimental and Clinical Psychopharmacology (2017)

Modern clinical research on LSD

Liechti, M. E. · Neuropsychopharmacology (2017)

The therapeutic potential of psychedelic drugs: past, present, and future

Carhart-Harris, R. L., Goodwin, G. M. · Neuropsychopharmacology (2017)

Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects

Borgwardt, S., Dolder, P. C., Harder, S. et al. · Translational Psychiatry (2017)

Pharmacokinetics and pharmacodynamics of lysergic acid diethylamide in healthy subjects

Dolder, P. C., Hammann, F., Kraemer, T. et al. · Clinical Pharmacokinetics (2017)

Phenomenology, Structure, and Dynamic of Psychedelic States

Preller, K. H., Vollenweider, F. X. · Behavioral Neurobiology of Psychedelic Drugs (2016)

Alterations of consciousness and mystical-type experiences after acute LSD in humans

Dolder, P. C., Liechti, M. E., Schmid, Y. · Psychopharmacology (2016)

190 cited
A placebo-controlled investigation of synaesthesia-like experiences under LSD

Bolstridge, M., Carhart-Harris, R. L., Feilding, A. et al. · Neuropsychologia (2016)

43 cited
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study

Bloomfield, M., Bolstridge, M., Carhart-Harris, R. L. et al. · Lancet Psychiatry (2016)

1174 cited
LSD acutely impairs fear recognition and enhances emotional empathy and sociality

Borgwardt, S., Dolder, P. C., Liechti, M. E. et al. · Neuropsychopharmacology (2016)

Neural correlates of the LSD experience revealed by multimodal neuroimaging

Bolstridge, M., Carhart-Harris, R. L., Curran, H. V. et al. · PNAS (2016)

Psychedelics

Nichols, D. E. · Pharmacological Reviews (2016)

Lysergic acid diethylamide: a drug of ‘use’?

Barnwal, P., Das, S., Mondal, S. et al. · Therapeutic Advances in Psychopharmacology (2016)

Decreased mental time travel to the past correlates with default-mode network disintegration under lysergic acid diethylamide

Carhart-Harris, R. L., Feilding, A., Kaelen, M. et al. · Journal of Psychopharmacology (2016)

113 cited
The paradoxical psychological effects of lysergic acid diethylamide (LSD)

Bolstridge, M., Carhart-Harris, R. L., Feilding, A. et al. · Psychological Medicine (2016)

253 cited
New World Tryptamine Hallucinogens and the Neuroscience of Ayahuasca

McKenna, D., Riba, J. · Current Topics in Behavioral Neurosciences (2016)

Serotonergic Hallucinogen-Induced Visual Perceptual Alterations

Kometer, M., Vollenweider, F. X. · Behavioral Neurobiology of Psychedelic Drugs (2016)

LSD enhances the emotional response to music

Barrett, F. S., Bolstridge, M., Carhart-Harris, R. L. et al. · Psychopharmacology (2015)

Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin

Carhart-Harris, R. L., Feilding, A., Lebedev, A. V. et al. · Human Brain Mapping (2015)

Your Library